Published in Am J Respir Crit Care Med on March 11, 2010
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J (2012) 3.00
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis. Clin Infect Dis (2012) 1.99
Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis (2013) 1.98
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2011) 1.29
Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis. Int J Infect Dis (2012) 1.01
Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res (2013) 1.01
Medical treatment of pulmonary multidrug-resistant tuberculosis. Infect Chemother (2013) 1.00
Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis. Antimicrob Agents Chemother (2012) 0.97
From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study. PLoS One (2013) 0.88
Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study. PLoS One (2014) 0.87
Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB. Yonsei Med J (2015) 0.85
Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients--a retrospective cohort study. PLoS One (2013) 0.84
Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible? PLoS Med (2016) 0.84
Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis. Antimicrob Agents Chemother (2013) 0.84
Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate. Antimicrob Agents Chemother (2013) 0.83
Novel regimens identified in mice for treatment of latent tuberculosis infection in contacts of patients with multidrug-resistant tuberculosis. Antimicrob Agents Chemother (2014) 0.83
Does Alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?. A population-based study in Kerala, India. Ann Am Thorac Soc (2014) 0.80
Map the gap: missing children with drug-resistant tuberculosis. Public Health Action (2015) 0.75
Streptomycin susceptibility and MDR-TB: can we refine the definition of XDR-TB? Am J Respir Crit Care Med (2011) 0.75
Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan. PLoS One (2017) 0.75
Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China. PLoS One (2017) 0.75
Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis. Chonnam Med J (2017) 0.75
WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea. Tuberc Respir Dis (Seoul) (2017) 0.75
The first Korean genome sequence and analysis: full genome sequencing for a socio-ethnic group. Genome Res (2009) 7.87
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet (2012) 6.78
Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med (2012) 6.73
Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med (2012) 5.87
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
The role of chest CT scanning in TB outbreak investigation. Chest (2009) 3.62
Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med (2008) 2.92
Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med (2012) 2.92
Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med (2005) 2.75
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J (2012) 2.61
Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol (2011) 2.49
Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother (2009) 2.47
Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect (2010) 2.41
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med (2009) 2.33
Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol (2003) 2.25
Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. J Clin Microbiol (2008) 2.24
Performances of prognostic scoring systems in patients with healthcare-associated pneumonia. Clin Infect Dis (2012) 2.23
Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis (2008) 2.17
Whole-genome sequencing and intensive analysis of the undomesticated soybean (Glycine soja Sieb. and Zucc.) genome. Proc Natl Acad Sci U S A (2010) 2.15
Bronchopleural fistula treated with a silicone-covered bronchial occlusion stent. Ann Thorac Surg (2010) 2.13
Exertional desaturation as a predictor of rapid lung function decline in COPD. Respiration (2012) 2.09
Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med (2013) 1.82
Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology (2004) 1.78
Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med (2005) 1.77
Clinical characteristics and efficacy of bronchoscopic intervention for tracheobronchial leiomyoma. Respirology (2008) 1.76
Pleuropulmonary paragonimiasis: CT findings in 31 patients. AJR Am J Roentgenol (2005) 1.76
Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. J Antimicrob Chemother (2012) 1.75
Clinical features of recently diagnosed pulmonary paragonimiasis in Korea. Chest (2005) 1.68
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2015) 1.68
Pulmonary inflammatory pseudotumor--a report of 28 cases. Korean J Intern Med (2002) 1.66
Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis. Am J Respir Crit Care Med (2013) 1.62
Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. J Antimicrob Chemother (2006) 1.61
Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy. Chest (2007) 1.60
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis? Chest (2007) 1.53
Optimal duration of IV and oral antibiotics in the treatment of thoracic actinomycosis. Chest (2005) 1.53
Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital. Infect Control Hosp Epidemiol (2009) 1.52
Serum cytokines and critical illness-related corticosteroid insufficiency. Intensive Care Med (2010) 1.51
Thyroid gland rupture after blunt cervical trauma. J Ultrasound Med (2006) 1.51
Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry (2013) 1.51
Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea. Acta Haematol (2013) 1.50
Thoracic actinomycosis: CT features with histopathologic correlation. AJR Am J Roentgenol (2006) 1.49
Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia. Respir Med (2012) 1.48
Pulmonary nocardiosis with multiple cavitary nodules in a HIV-negative immunocompromised patient. Intern Med (2004) 1.47
Biphasic late airway hyperresponsiveness in a murine model of asthma. Int Arch Allergy Immunol (2012) 1.46
Fusion image-based programming after subthalamic nucleus deep brain stimulation. World Neurosurg (2011) 1.45
Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers. Support Care Cancer (2013) 1.44
Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens. Int J Urol (2011) 1.42
Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med (2012) 1.41
Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest (2007) 1.40
Concurrent endobronchial carcinoid tumor and sarcoidosis. Intern Med (2010) 1.40
Repeated derecruitments accentuate lung injury during mechanical ventilation. Crit Care Med (2013) 1.40
Increased tuberculosis burden due to demographic transition in Korea from 2001 to 2010. Tuberc Respir Dis (Seoul) (2013) 1.40
Tuberculous lymphadenitis of the thorax: comparisons of imaging findings between patients with and those without HIV infection. AJR Am J Roentgenol (2012) 1.39
Recurrent traumatic urethral strictures near the external sphincter: treatment with a covered, retrievable, expandable nitinol stent--initial results. Radiology (2003) 1.38
Retracted A Novel Carbamoyloxy Arylalkanoyl Arylpiperazine Compound (SKL-NP) Inhibits Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Currents in Rat Dorsal Root Ganglion Neurons. Korean J Physiol Pharmacol (2012) 1.37
Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol Cell Biol (2002) 1.35
Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis (2009) 1.35
Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity. J Thorac Oncol (2012) 1.34
Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD (2013) 1.32
Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis (2009) 1.32
Characteristics of body fat, body fat percentage and other body composition for Koreans from KNHANES IV. J Korean Med Sci (2011) 1.31
Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. BMC Infect Dis (2011) 1.30
Treatment of thoracic actinomycosis: A retrospective analysis of 40 patients. Ann Thorac Med (2010) 1.28
A retrograde signal from calsequestrin for the regulation of store-operated Ca2+ entry in skeletal muscle. J Biol Chem (2002) 1.28
Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector. J Korean Med Sci (2010) 1.26
Whole transcriptome analyses of six thoroughbred horses before and after exercise using RNA-Seq. BMC Genomics (2012) 1.26
Ordered nanowire array blue/near-UV light emitting diodes. Adv Mater (2010) 1.25
Solid-organ malignancy as a risk factor for tuberculosis. Respirology (2008) 1.25
Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy. Chest (2005) 1.25
Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology (2010) 1.24
Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J Immunol (2005) 1.24
Carbon monoxide activates autophagy via mitochondrial reactive oxygen species formation. Am J Respir Cell Mol Biol (2011) 1.23
Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol (2013) 1.22
Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice. PLoS One (2013) 1.22
The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis. J Korean Med Sci (2011) 1.22
Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med (2009) 1.21
Treatment outcomes for patients with synchronous multiple primary non-small cell lung cancer. Lung Cancer (2010) 1.21
Obesity, insulin resistance and cancer risk. Yonsei Med J (2005) 1.20
Pulmonary mycobacterial disease: diagnostic performance of low-dose digital tomosynthesis as compared with chest radiography. Radiology (2010) 1.20
Impact of toxocariasis in patients with unexplained patchy pulmonary infiltrate in Korea. J Korean Med Sci (2009) 1.20
Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg (2004) 1.20
EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases. Clin Lung Cancer (2011) 1.19
Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation. Exp Mol Med (2002) 1.18
Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis (2010) 1.17
Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med (2008) 1.17
Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe (2012) 1.16